Search

everythinglearnresearchcommunity

for

Search:↓

Sons of mothers with polycystic ovary syndrome (PCOS) have a higher risk of obesity and insulin resistance, possibly due to certain genes and factors passed down from their mothers.

N-acetylcysteine may prevent hair loss caused by chemotherapy.

PCOS is managed by lifestyle changes and personalized medication to improve symptoms and fertility.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might reduce it. AST decreases recurrence-free survival but doesn't affect overall survival or progression-free survival. More research is needed to understand AST's benefits.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might decrease the risk. AST also lessens the chance of cancer coming back but doesn't really affect survival rates. More research is needed to understand AST's benefits for different bladder cancers.

PCOS affects many aspects of health, not just fertility, and needs comprehensive treatment.

The article concludes that better diagnosis and management of Polycystic Ovarian Syndrome are needed to improve women's health and prevent related diseases.

Women with PCOS face many health risks, but exercise, a healthy diet, and weight management can help.

The article suggests renaming Polycystic Ovarian Syndrome (PCOS) to "Hyperandrogenic Persistent Ovulatory Dysfunction Syndrome" (HA-PODS) for accuracy and consistency, but no final decision was made.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

Finasteride helps induce ovulation in nonresponder PCOS women.

The document concludes that more research is needed to understand how PRP affects the ovaries and to standardize its use in treatment.

Certain genetic variations are linked to increased androgen levels in PCOS, but more research is needed to understand these connections fully.

Polycystic ovary syndrome is a complex condition that affects women's mental, reproductive, and metabolic health throughout their lives.

The update highlights that non-classic congenital adrenal hyperplasia is common in women with excess male hormones, requires specific hormone tests for diagnosis, and has various treatment options depending on age and symptoms.

Children with autoimmune gastritis showed improved intestinal health over time and should be checked for other autoimmune conditions.

Hyperadrenocorticism in ferrets is linked to neutering and indoor housing, and is best treated with surgery and a deslorelin implant.

The document concludes that more research is needed to include new treatments in guidelines for Polycystic Ovary Syndrome (PCOS).

Too much prolactin can cause menstrual problems, infertility, and sexual issues in women.

PCOS is a hormonal disorder causing symptoms like irregular periods and acne, and increases the risk of diabetes and heart disease.

Certain microRNAs in the fluid around eggs are linked to Polycystic Ovary Syndrome and may help diagnose it.

Myo-inositol may be more effective than metformin for inducing ovulation in women with PCOS.

The study found a significant link between the renin-angiotensin system and insulin resistance in women with polycystic ovary syndrome.

Certain genetic markers linked to reproductive potential were identified by their impact on a protein's ability to bind to genes.

We need better ways to test and understand SARMs to make safer and more effective treatments.

Polycystic ovarian shape is a genetic sign of PCOS and its hormonal and metabolic features can be inherited.

Women with PCOS have fewer activated T cells in their ovarian follicles, which might affect fertility.

Polycystic Ovary Syndrome is linked to higher risk of hypertension and heart disease.

Women with only irregular periods or excess hair have a better hormone profile than those with full PCOS, but both groups are similar, indicating a need for better PCOS diagnosis methods.

Treatment with a hormone agonist can reduce excess male hormones in postmenopausal women without surgery.